BK virus antibody titers and intensity of infections after renal transplantation

Journal of Clinical Virology

Volumn 43, Issue 2, 2008, Pages 184-189

  Bohl, Daniel L ^a   Brennan, Daniel C ^a   Ryschkewitsch, Caroline ^b   Gaudreault Keener, Monique ^c   Major, Eugene O ^b   Storch, Gregory A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

BK virus; BK antibody; BK viremia; Humoral immunity; Kidney; Polyomavirus; Transplantation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; ARTICLE; BK VIRUS; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; VIREMIA; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BK VIRUS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIREMIA; YOUNG ADULT;

EID: 50849106683     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.06.009     Document Type: Article

References (22)

1. Gardner S.D., Field A.M., Coleman D.V., and Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1 (1971) 1253-1257
2. Knowles W.A., Khalili K., and Stoner G. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. Human polyomaviruses: molecular and clinical prospectives (2001), Wiley-Liss Inc., New York p. 527-560
3. Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71 (2003) 115-123
4. Hirsch H.H., and Steiger J. Polyomavirus BK. Lancet Infect Dis 3 (2003) 611-623
5. Ginevri F., De Santis R., Comoli P., Pastorino N., Rossi C., Botti G., et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 75 (2003) 1266-1270
6. Smith J.M., McDonald R.A., Finn L.S., Healey P.J., Davis C.L., and Limaye A.P. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transpl 4 (2004) 2109-2117
7. Andrews C., Shah K.V., Rubin R., and Hirsch M. BK papovavirus infections in renal transplant recipients: contribution of donor kidneys. J Infect Dis 145 (1982) 276
8. Bohl D.L., Storch G.A., Ryschkewitsch C., Gaudreault-Keener M., Schnitzler M.A., Major E.O., et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transpl 5 (2005) 2213-2221
9. Hirsch H.H., Knowles W., Dickenmann M., Passweg J., Klimkait T., Mihatsch M.J., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347 (2002) 488-496
10. Gardner S.D., MacKenzie E.F., Smith C., and Porter A.A. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 37 (1984) 578-586
11. Hariharan S., Cohen E.P., Vasudev B., Orentas R., Viscidi R.P., Kakela J., et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transpl 5 (2005) 2719-2724
12. Brennan D.C., Agha I., Bohl D.L., Schnitzler M.A., Hardinger K.L., Lockwood M., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transpl 5 (2005) 582-594
13. Hamilton R.S., Gravell M., and Major E.O. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 38 (2000) 105-109
14. Viscidi R.P., Rollison D.E., Viscidi E., Clayman B., Rubalcaba E., Daniel R., et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 10 (2003) 278-285
15. Randhawa P.S., Gupta G., Vats A., Shapiro R., and Viscidi R.P. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 13 (2006) 1057-1063
16. Sener A., House A.A., Jevnikar A.M., Boudville N., McAlister V.C., Muirhead N., et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 81 (2006) 117-120
17. Keven K., Sahin M., Kutlay S., Sengul S., Erturk S., Ersoz S., et al. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 5 (2003) 181-186
18. Rentenaar R.J., van Diepen F.N., Meijer R.T., Surachno S., Wilmink J.M., Schellekens P.T., et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 62 (2002) 319-328
19. Smith K.G., Isbel N.M., Catton M.G., Leydon J.A., Becker G.J., and Walker R.G. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transpl 13 (1998) 160-164
20. Ginevri F., Azzi A., Hirsch H.H., Basso S., Fontana I., Cioni M., et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7 12 (2007) 2727-2735
21. Binggeli S., Egli A., Schaub S., Binet I., Mayr M., Steiger J., et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transpl 7 (2007) 1131-1139
22. Comoli P., Azzi A., Maccario R., Basso S., Botti G., Basile G., et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78 (2004) 1229-1232